Clinical trials
Completed Insulin Resistance trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
74 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 4 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 6 |
| 2010 | 6 |
| 2011 | 6 |
| 2012 | 5 |
| 2013 | 1 |
| 2014 | 7 |
| 2015 | 4 |
| 2016 | 6 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 74 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Maastricht University Medical Center | 36 |
| Amsterdam UMC, location VUmc | 6 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 4 |
| Radboud University Medical Center | 4 |
| Maastricht University | 3 |
| TNO | 3 |
| Leiden University Medical Center | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| AstraZeneca | 1 |
| German Diabetes Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Insulin Resistance | 74 |
| Obesity | 22 |
| Diabetes Mellitus, Type 2 | 21 |
| Glucose Intolerance | 8 |
| Diabetes Mellitus | 6 |
| Overweight | 6 |
| Hypertension | 5 |
| Glucose Metabolism Disorders | 4 |
| Diabetes Mellitus, Type 1 | 3 |
| Dyslipidemias | 3 |
Trials
Showing 1 to 25 of 74. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.